• Skip to main content

Signature Dermatology

(972) 521-3240
Fax Us
(972) 505-2551
Call or Securely Text
Schedule Appointment
  • Locations
  • Providers
  • Services
    • Cosmetic Dermatology
      • Acne/Acne Scars
      • Aging / Sun Damaged Skin
      • BBL Photofacial
      • Chemical Peel
      • Dermal Fillers
      • Dysport
      • HydraFacial
      • Kybella
      • Laser Hair Removal
      • Laser Skin Resurfacing
      • Hair Restoration
      • Microneedling
      • Halo
      • BBL Hero
      • Sylfirm X
      • UltraClear Laser Resurfacing
      • ResurFX
      • M22 IPL
    • Medical Dermatology
      • Actinic Keratosis
      • Alopecia Areata
      • Athlete’s Foot
      • Bullous Pemphigoid
      • Cysts
      • Excessive Perspiration
      • Hair Loss
      • Hives
      • Impetigo
      • Folliculitis / Ingrown Hairs
      • Keratosis Pilaris
      • Lichen Planus
      • Lumps, Bumps and Moles
      • Lupus
      • Melanoma
      • Melasma
      • Nail Disorders
      • Poison Ivy
      • Psoriasis
      • Rashes
      • Rosacea
      • Seborrheic Keratosis
      • Shingles (Herpes Zoster)
      • Skin Cancer
      • Vitiligo (Skin Pigment Disorders)
      • Warts
    • Pediatric Dermatology
      • “Baby” Eczema
      • “Cradle cap” (Seborrhea)
      • “Salmon patches” or “Stork bites”
      • Inherited/Genetic Skin Conditions
      • Moles (suspicious)
      • Diaper Rash
      • Skin Rashes
      • Sunburn
      • Warts
    • Phototherapy (Light Therapy)
      • NB UVB/XTRAC
      • Photodynamic Therapy (PDT)
    • Surgical and Procedural Dermatology
      • Melanoma
      • Mohs Micrographic Surgery
      • Skin Cancer
      • Superficial Radiation Therapy (SRT)
      • TheraClearX
  • Skin Tightening
  • Hair Restoration
  • Contact
    • About
    • Events/Promo
    • Patient Resources
    • Bill Pay
  • Shop
LnRiLWhlYWRpbmcuaGFzLWJhY2tncm91bmR7cGFkZGluZzowfQ==
.tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="1a4fe63c6bb9d766678ba740bf1deeb9"] { padding: 25px; } .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="1a4fe63c6bb9d766678ba740bf1deeb9"] > .tb-container-inner { max-width: 370px; } .tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="542d4b0c7afbe0f18d0c3ad60f0c89b8"] { border-radius: 15px;padding: 0px; } .tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="40d874d9c9be6099132f93d4ee4d03ab"] { padding: 25px 25px 0px 25px;min-height: 260px; } h5.tb-heading[data-toolset-blocks-heading="5fc22a8967c83120c97f952ace2c9c14"]  { font-weight: bold;text-align: left; }  .tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="a3ac114953929834fc5bb610d51e3583"] { border-radius: 15px 15px 0 0;background: url('') center center no-repeat;background-size:cover;padding: 0px 25px 25px 25px;min-height: 180px; } .tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end}.tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="43be6d0f85d4e837ae854ff8f646bcfd"] { padding: 25px;display:ms-flexbox !important;display:flex !important;-ms-flex-direction:column;flex-direction:column;-ms-flex-pack:center;justify-content:center; } .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="43be6d0f85d4e837ae854ff8f646bcfd"] > .tb-container-inner { max-width: 1200px; } .tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="0c5e9cd96aac60a44d46eb3904c062d0"] { padding: 0px 25px 0px 25px;min-height: 600px; } .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="0c5e9cd96aac60a44d46eb3904c062d0"] > .tb-container-inner { max-width: 1200px; } .tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="4baf953828280701fc9fde7b051f2f78"] { padding: 0px 25px 0px 25px;margin-top: 10px;margin-bottom: 20px;display:ms-flexbox !important;display:flex !important;-ms-flex-direction:column;flex-direction:column;-ms-flex-pack:center;justify-content:center; } .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="4baf953828280701fc9fde7b051f2f78"] > .tb-container-inner { max-width: 1200px; } .tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end} .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="257ef336830b15e0a069e1e06f875487"] { padding: 0px;margin: 0px;grid-template-columns: minmax(0, 0.5fr) minmax(0, 0.5fr);grid-auto-flow: row } .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="257ef336830b15e0a069e1e06f875487"] > .tb-grid-column:nth-of-type(2n + 1) { grid-column: 1 } .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="257ef336830b15e0a069e1e06f875487"] > .tb-grid-column:nth-of-type(2n + 2) { grid-column: 2 } .tb-social-share__network{display:inline-block;text-align:center;vertical-align:top;margin-right:7px;margin-bottom:7px}.tb-social-share--092 .tb-social-share__facebook__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#3b5998;}.tb-social-share--092 .tb-social-share__linkedin__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#007fb1;}.tb-social-share--092 .tb-social-share__twitter__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#00aced;}.tb-social-share--092 .tb-social-share__pinterest__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#cb2128;}.tb-social-share--092 .tb-social-share__telegram__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#37aee2;}.tb-social-share--092 .tb-social-share__reddit__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#5f99cf;}.tb-social-share--092 .tb-social-share__viber__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#7c529e;}.tb-social-share--092 .tb-social-share__email__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#7f7f7f;}.tb-social-share--round .SocialMediaShareButton{border-radius:50%}.tb-social-share__excerpt{display:none}.tb-social-share .SocialMediaShareButton--disabled{opacity:0.65} .tb-social-share[data-toolset-blocks-social-share="715353fd94da678e4ffc48d05ac8787a"] { text-align: right; } .tb-social-share[data-toolset-blocks-social-share="715353fd94da678e4ffc48d05ac8787a"] .SocialMediaShareButton { width: 32px;height: 32px; } .wp-block-toolset-blocks-grid-column.tb-grid-column[data-toolset-blocks-grid-column="3034fbe886c11054e95b46b09d3e4112"] { display: flex; } .tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="abe29a0c63e74ed11371017bafb6a1b5"] { background: rgba( 237, 234, 230, 1 );padding: 0px; } .tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="ecaa789acf2a1988475d687785af0314"] { background: url('https://westdermdev.wpengine.com/wp-content/uploads/2022/06/rachel-wave.png') center bottom no-repeat;background-size:contain;padding: 20px 25px 50px 25px;min-height: 200px;display:ms-flexbox !important;display:flex !important;-ms-flex-direction:column;flex-direction:column;-ms-flex-pack:center;justify-content:center; } .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="ecaa789acf2a1988475d687785af0314"] > .tb-container-inner { max-width: 1200px; } h1.tb-heading[data-toolset-blocks-heading="b2a5c382742d8c11977dd1e1310a7cca"]  { font-size: 42px;font-weight: bold; }  @media only screen and (max-width: 781px) { .tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="1a4fe63c6bb9d766678ba740bf1deeb9"] { padding: 0px;margin: 15px; } .tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto} .tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end}.tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end} .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="257ef336830b15e0a069e1e06f875487"] { grid-template-columns: minmax(0, 0.5fr) minmax(0, 0.5fr);grid-auto-flow: row } .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="257ef336830b15e0a069e1e06f875487"] > .tb-grid-column:nth-of-type(2n + 1) { grid-column: 1 } .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="257ef336830b15e0a069e1e06f875487"] > .tb-grid-column:nth-of-type(2n + 2) { grid-column: 2 } .tb-social-share__network{display:inline-block;text-align:center;vertical-align:top;margin-right:7px;margin-bottom:7px}.tb-social-share--092 .tb-social-share__facebook__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#3b5998;}.tb-social-share--092 .tb-social-share__linkedin__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#007fb1;}.tb-social-share--092 .tb-social-share__twitter__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#00aced;}.tb-social-share--092 .tb-social-share__pinterest__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#cb2128;}.tb-social-share--092 .tb-social-share__telegram__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#37aee2;}.tb-social-share--092 .tb-social-share__reddit__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#5f99cf;}.tb-social-share--092 .tb-social-share__viber__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#7c529e;}.tb-social-share--092 .tb-social-share__email__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#7f7f7f;}.tb-social-share--round .SocialMediaShareButton{border-radius:50%}.tb-social-share__excerpt{display:none}.tb-social-share .SocialMediaShareButton--disabled{opacity:0.65}.wp-block-toolset-blocks-grid-column.tb-grid-column[data-toolset-blocks-grid-column="3034fbe886c11054e95b46b09d3e4112"] { display: flex; } .tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="ecaa789acf2a1988475d687785af0314"] { background: url('https://westdermdev.wpengine.com/wp-content/uploads/2022/06/rachel-wave.png') center bottom no-repeat;background-size:contain;padding: 20px 25px 40px 25px;min-height: 175px; }   } @media only screen and (max-width: 599px) { .tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto} .tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end}.tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end} .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="257ef336830b15e0a069e1e06f875487"] { grid-template-columns: minmax(0, 1fr);grid-auto-flow: row } .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="257ef336830b15e0a069e1e06f875487"]  > .tb-grid-column:nth-of-type(1n+1) { grid-column: 1 } .tb-social-share__network{display:inline-block;text-align:center;vertical-align:top;margin-right:7px;margin-bottom:7px}.tb-social-share--092 .tb-social-share__facebook__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#3b5998;}.tb-social-share--092 .tb-social-share__linkedin__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#007fb1;}.tb-social-share--092 .tb-social-share__twitter__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#00aced;}.tb-social-share--092 .tb-social-share__pinterest__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#cb2128;}.tb-social-share--092 .tb-social-share__telegram__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#37aee2;}.tb-social-share--092 .tb-social-share__reddit__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#5f99cf;}.tb-social-share--092 .tb-social-share__viber__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#7c529e;}.tb-social-share--092 .tb-social-share__email__share-button{cursor:pointer;display:inline-block;background-size:contain;background-color:#7f7f7f;}.tb-social-share--round .SocialMediaShareButton{border-radius:50%}.tb-social-share__excerpt{display:none}.tb-social-share .SocialMediaShareButton--disabled{opacity:0.65}.wp-block-toolset-blocks-grid-column.tb-grid-column[data-toolset-blocks-grid-column="3034fbe886c11054e95b46b09d3e4112"] { display: flex; } .tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="ecaa789acf2a1988475d687785af0314"] { background: rgba( 230, 243, 247, 1 );padding: 20px 10px 20px 10px;margin-top: 65px;min-height: 150px; }   } 

Important COVID Vaccine Update 🎉

February 4, 2021
You may have read that in the Moderna COVID-19 vaccine trial only, 3 of the 30,000 participants as of December 2020 experienced temporary facial swelling. Of these 3 people, 2 received the vaccine and 1 received the placebo. The person who received the placebo had dental work two weeks prior. All 3 of these people had a history of receiving facial fillers. The swelling did subside in a few days without any adverse effects. What does this mean for facial filler patients?
As you may be aware, facial swelling is a known possible rare side effect of filler injections. It is usually brought on by the addition of other stressors, such as recent dental work, illness like the flu, or other vaccines. Of the other 29,997 vaccine trial participants, we do not know who among them had a history of receiving facial fillers but did not experience facial swelling after receiving the vaccine. Further, we are not sure if the swelling was caused by the interaction between the facial filler and the vaccine, although it is possible.
We do not recommend avoiding the COVID-19 vaccine if you are a facial filler recipient. We encourage all patients who are able to receive a COVID-19 vaccine to get one, even those who have received facial fillers.
Do not hesitate to contact us if you have any questions or concerns about swelling. Just remember that swelling has always been an extremely rare, mild, reversible side effect of facial fillers, and the swelling that the 3 vaccine trial participants experienced resolved quickly without any adverse effects. If swelling does occur, we can also recommend treatment options to swiftly cause its resolution.
We hope this explanation helps clarify the results of the COVID-19 vaccine trials. Our clinics will continue to abide by the best possible safety precautions to keep our patients and staff healthy during this time. Please continue to wear a mask, even two when in proximity to those not in your household, even after you’ve received the vaccine, until the CDC advises otherwise.
Home » Important COVID Vaccine Update 🎉
You may have read that in the Moderna COVID-19 vaccine trial only, 3 of the 30,000 participants as of December 2020 experienced temporary facial swelling. Of these 3 people, 2 received the vaccine and 1 received the placebo. The person who received the placebo had dental work two weeks prior. All 3 of these people had a history of receiving facial fillers. The swelling did subside in a few days without any adverse effects. What does this mean for facial filler patients?
As you may be aware, facial swelling is a known possible rare side effect of filler injections. It is usually brought on by the addition of other stressors, such as recent dental work, illness like the flu, or other vaccines. Of the other 29,997 vaccine trial participants, we do not know who among them had a history of receiving facial fillers but did not experience facial swelling after receiving the vaccine. Further, we are not sure if the swelling was caused by the interaction between the facial filler and the vaccine, although it is possible.
We do not recommend avoiding the COVID-19 vaccine if you are a facial filler recipient. We encourage all patients who are able to receive a COVID-19 vaccine to get one, even those who have received facial fillers.
Do not hesitate to contact us if you have any questions or concerns about swelling. Just remember that swelling has always been an extremely rare, mild, reversible side effect of facial fillers, and the swelling that the 3 vaccine trial participants experienced resolved quickly without any adverse effects. If swelling does occur, we can also recommend treatment options to swiftly cause its resolution.
We hope this explanation helps clarify the results of the COVID-19 vaccine trials. Our clinics will continue to abide by the best possible safety precautions to keep our patients and staff healthy during this time. Please continue to wear a mask, even two when in proximity to those not in your household, even after you’ve received the vaccine, until the CDC advises otherwise.
Previous
Next

Suggested Reads

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

December 2, 2025

High Altitude, High Impact: Ways Flying Affects Your Skin 

As holiday travel surges, many of us are preparing for flights, family gatherings, and fes…

LnRiLWNvbnRhaW5lciAudGItY29udGFpbmVyLWlubmVye3dpZHRoOjEwMCU7bWFyZ2luOjAgYXV0b30gLndwLWJsb2NrLXRvb2xzZXQtYmxvY2tzLWNvbnRhaW5lci50Yi1jb250YWluZXJbZGF0YS10b29sc2V0LWJsb2Nrcy1jb250YWluZXI9IjFhNGZlNjNjNmJiOWQ3NjY2NzhiYTc0MGJmMWRlZWI5Il0geyBwYWRkaW5nOiAyNXB4OyB9IC53cC1ibG9jay10b29sc2V0LWJsb2Nrcy1jb250YWluZXIudGItY29udGFpbmVyW2RhdGEtdG9vbHNldC1ibG9ja3MtY29udGFpbmVyPSIxYTRmZTYzYzZiYjlkNzY2Njc4YmE3NDBiZjFkZWViOSJdID4gLnRiLWNvbnRhaW5lci1pbm5lciB7IG1heC13aWR0aDogMzcwcHg7IH0gLnRiLWNvbnRhaW5lciAudGItY29udGFpbmVyLWlubmVye3dpZHRoOjEwMCU7bWFyZ2luOjAgYXV0b30gLndwLWJsb2NrLXRvb2xzZXQtYmxvY2tzLWNvbnRhaW5lci50Yi1jb250YWluZXJbZGF0YS10b29sc2V0LWJsb2Nrcy1jb250YWluZXI9IjU0MmQ0YjBjN2FmYmUwZjE4ZDBjM2FkNjBmMGM4OWI4Il0geyBib3JkZXItcmFkaXVzOiAxNXB4O3BhZGRpbmc6IDBweDsgfSAudGItY29udGFpbmVyIC50Yi1jb250YWluZXItaW5uZXJ7d2lkdGg6MTAwJTttYXJnaW46MCBhdXRvfSAud3AtYmxvY2stdG9vbHNldC1ibG9ja3MtY29udGFpbmVyLnRiLWNvbnRhaW5lcltkYXRhLXRvb2xzZXQtYmxvY2tzLWNvbnRhaW5lcj0iNDBkODc0ZDljOWJlNjA5OTEzMmY5M2Q0ZWU0ZDAzYWIiXSB7IHBhZGRpbmc6IDI1cHggMjVweCAwcHggMjVweDttaW4taGVpZ2h0OiAyNjBweDsgfSBoNS50Yi1oZWFkaW5nW2RhdGEtdG9vbHNldC1ibG9ja3MtaGVhZGluZz0iNWZjMjJhODk2N2M4MzEyMGM5N2Y5NTJhY2UyYzljMTQiXSAgeyBmb250LXdlaWdodDogYm9sZDt0ZXh0LWFsaWduOiBsZWZ0OyB9ICAudGItY29udGFpbmVyIC50Yi1jb250YWluZXItaW5uZXJ7d2lkdGg6MTAwJTttYXJnaW46MCBhdXRvfSAud3AtYmxvY2stdG9vbHNldC1ibG9ja3MtY29udGFpbmVyLnRiLWNvbnRhaW5lcltkYXRhLXRvb2xzZXQtYmxvY2tzLWNvbnRhaW5lcj0iYTNhYzExNDk1MzkyOTgzNGZjNWJiNjEwZDUxZTM1ODMiXSB7IGJvcmRlci1yYWRpdXM6IDE1cHggMTVweCAwIDA7YmFja2dyb3VuZDogdXJsKCcnKSBjZW50ZXIgY2VudGVyIG5vLXJlcGVhdDtiYWNrZ3JvdW5kLXNpemU6Y292ZXI7cGFkZGluZzogMHB4IDI1cHggMjVweCAyNXB4O21pbi1oZWlnaHQ6IDE4MHB4OyB9IEBtZWRpYSBvbmx5IHNjcmVlbiBhbmQgKG1heC13aWR0aDogNzgxcHgpIHsgLnRiLWNvbnRhaW5lciAudGItY29udGFpbmVyLWlubmVye3dpZHRoOjEwMCU7bWFyZ2luOjAgYXV0b30gLndwLWJsb2NrLXRvb2xzZXQtYmxvY2tzLWNvbnRhaW5lci50Yi1jb250YWluZXJbZGF0YS10b29sc2V0LWJsb2Nrcy1jb250YWluZXI9IjFhNGZlNjNjNmJiOWQ3NjY2NzhiYTc0MGJmMWRlZWI5Il0geyBwYWRkaW5nOiAwcHg7bWFyZ2luOiAxNXB4OyB9IC50Yi1jb250YWluZXIgLnRiLWNvbnRhaW5lci1pbm5lcnt3aWR0aDoxMDAlO21hcmdpbjowIGF1dG99LnRiLWNvbnRhaW5lciAudGItY29udGFpbmVyLWlubmVye3dpZHRoOjEwMCU7bWFyZ2luOjAgYXV0b30gLnRiLWNvbnRhaW5lciAudGItY29udGFpbmVyLWlubmVye3dpZHRoOjEwMCU7bWFyZ2luOjAgYXV0b30gfSBAbWVkaWEgb25seSBzY3JlZW4gYW5kIChtYXgtd2lkdGg6IDU5OXB4KSB7IC50Yi1jb250YWluZXIgLnRiLWNvbnRhaW5lci1pbm5lcnt3aWR0aDoxMDAlO21hcmdpbjowIGF1dG99LnRiLWNvbnRhaW5lciAudGItY29udGFpbmVyLWlubmVye3dpZHRoOjEwMCU7bWFyZ2luOjAgYXV0b30udGItY29udGFpbmVyIC50Yi1jb250YWluZXItaW5uZXJ7d2lkdGg6MTAwJTttYXJnaW46MCBhdXRvfSAudGItY29udGFpbmVyIC50Yi1jb250YWluZXItaW5uZXJ7d2lkdGg6MTAwJTttYXJnaW46MCBhdXRvfSB9IA==

December 2, 2025

Perfect Timing: How to Know When You’re Ready for Neuromodulators 

A common question is “when should I start Dysport or Botox, am I too young, or did I wait…

November 21, 2025

Skincare Stocking Stuffers for Everyone on Your List 

The holiday season is officially here, and so is the search for the perfect stocking…

Signature Dermatology

About Us
Health Library
Patient Resource

Find Care

Locations
Providers

Referring Physicians

Please Fax:
(972) 521-3240

Connect With Us

© 2024 Signature Dermatology & Aesthetics. All Rights Reserved. | Sitemap | Privacy Policy | Notice of Privacy Practices | Terms of Service

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Copyright © 2025 · Dynamik-Gen on Genesis Framework · WordPress · Log in

Signature DermatologyLogo Header Menu
  • Home
  • Locations
  • Providers
  • Services
    • Cosmetic Dermatology
      • Acne/Acne Scars
      • Aging / Sun Damaged Skin
      • BBL Photofacial
      • Chemical Peel
      • Dermal Fillers
      • Dysport
      • HydraFacial
      • Kybella
      • Laser Hair Removal
      • Laser Skin Resurfacing
      • Hair Restoration
      • Microneedling
      • Halo
      • BBL Hero
      • Sylfirm X
      • UltraClear Laser Resurfacing
      • M22 IPL
      • ResurFX
      • Sofwave™
    • Medical Dermatology
      • Actinic Keratosis
      • Alopecia Areata
      • Athlete’s Foot
      • Bullous Pemphigoid
      • Cysts
      • Excessive Perspiration
      • Hair Loss
      • Hives
      • Impetigo
      • Folliculitis / Ingrown Hairs
      • Keratosis Pilaris
      • Lichen Planus
      • Lumps, Bumps and Moles
      • Lupus
      • Melanoma
      • Melasma
      • Nail Disorders
      • Poison Ivy
      • Psoriasis
      • Rashes
      • Rosacea
      • Seborrheic Keratosis
      • Shingles (Herpes Zoster)
      • Skin Cancer
      • Vitiligo (Skin Pigment Disorders)
      • Warts
    • Pediatric Dermatology
      • “Baby” Eczema
      • “Cradle cap” (Seborrhea)
      • “Salmon patches” or “Stork bites”
      • Inherited/Genetic Skin Conditions
      • Moles (suspicious)
      • Diaper Rash
      • Skin Rashes
      • Sunburn
      • Warts
    • Phototherapy (Light Therapy)
      • NB UVB/XTRAC
      • Photodynamic Therapy (PDT)
    • Surgical and Procedural Dermatology
      • Melanoma
      • Mohs Micrographic Surgery
      • Skin Cancer
      • Superficial Radiation Therapy (SRT)
      • TheraClearX
  • Sofwave
  • Sylfirm
  • Health Library
  • About
  • Events/Promo
  • Patient Resources
  • Pay Bill
  • Patient Portal
  • Book Appointment